HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyotaka Hitomi Selected Research

transglutaminase 1

11/2015Early response as shown by enhancement of transglutaminase 1 expression after cisplatin-induced acute kidney injury.
6/2015Lamellar ichthyosis with pseudoexon activation in the transglutaminase 1 gene.
3/2012Knocking-in the R142C mutation in transglutaminase 1 disrupts the stratum corneum barrier and postnatal survival of mice.
4/2010Transglutaminase1 preferred substrate peptide K5 is an efficient tool in diagnosis of lamellar ichthyosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyotaka Hitomi Research Topics

Disease

4Fibrosis (Cirrhosis)
01/2021 - 01/2017
4Neoplasms (Cancer)
11/2015 - 10/2010
3Lamellar Ichthyosis (Harlequin Ichthyosis)
06/2015 - 04/2010
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021
1Chronic Disease (Chronic Diseases)
01/2020
1Disease Progression
12/2018
1IGA Glomerulonephritis (IGA Nephropathy)
12/2018
1Hyperoxia
01/2018
1Bronchopulmonary Dysplasia
01/2018
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2017
1Carcinogenesis
03/2016
1Hepatocellular Carcinoma (Hepatoma)
03/2016
1Inflammation (Inflammations)
03/2016
1Renal Insufficiency (Renal Failure)
11/2015
1Acute Kidney Injury (Acute Renal Failure)
11/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2015
1Stroke (Strokes)
03/2015
1Obesity
08/2014
1Basal Cell Carcinoma (Rodent Ulcer)
06/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2014
1Keratosis
06/2014
1Ataxia (Dyssynergia)
03/2013
1Congenital Ichthyosiform Erythroderma
03/2012
1Ichthyosis (Xeroderma)
03/2012
1Alopecia (Baldness)
10/2010
1Cicatrix (Scar)
10/2010
1Lung Neoplasms (Lung Cancer)
08/2008
1Dehydration (Water Stress)
05/2004

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2014
7TransglutaminasesIBA
01/2021 - 06/2014
7EnzymesIBA
01/2020 - 08/2008
4Protein Glutamine gamma Glutamyltransferase 2IBA
01/2021 - 08/2008
4transglutaminase 1IBA
11/2015 - 04/2010
3IsoenzymesIBA
01/2020 - 01/2017
3Peptides (Polypeptides)IBA
01/2017 - 04/2010
2CollagenIBA
01/2018 - 10/2015
2Cystatin MIBA
10/2010 - 05/2004
1Extracellular Matrix ProteinsIBA
01/2020
1Immunoglobulin A (IgA)IBA
12/2018
1Lysine (L-Lysine)FDA Link
01/2018
1Glutamine (L-Glutamine)FDA Link
01/2018
1ScleroproteinsIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
03/2016
13,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
03/2016
1COUP Transcription Factor IIIBA
03/2016
1Linoleic Acid (Linoleate)IBA
03/2016
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
03/2016
1Pharmaceutical PreparationsIBA
03/2016
1LipidsIBA
03/2016
1Arachidonic Acid (Vitamin F)IBA
03/2016
1Cisplatin (Platino)FDA LinkGeneric
11/2015
1CreatinineIBA
11/2015
1Biomarkers (Surrogate Marker)IBA
11/2015
1Transcription Factors (Transcription Factor)IBA
10/2015
1Desoxycorticosterone Acetate (DOCA)FDA Link
03/2015
1SaltsIBA
03/2015
1Factor XIII (Coagulation Factor XIII)IBA
08/2014
1AutoantibodiesIBA
03/2013
1Glutens (Glutelin)IBA
03/2013
1Protease Inhibitors (Protease Inhibitor)IBA
10/2010
1Cysteine Proteinase InhibitorsIBA
05/2004

Therapy/Procedure

1Chemoprevention
03/2016